Search

everythinglearnresearchcommunity

for

Search:↓

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Cell adhesion molecules are important in the development of certain skin diseases.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

CD133+ cells help heal diabetic ulcers by promoting blood vessel growth and activating Wnt signaling.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Lower proximal cup cells, not bulge stem cells, regenerate hair follicles after chemotherapy.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Human thymus has stem cells that can self-renew and maintain their identity.

Murine cytomegalovirus does not cause alopecia areata in these mice.

ILC1 cells contribute to hair loss in alopecia areata.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Modulating the BTNL2 pathway can prevent hair loss in mice.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Stat3 activation increases hair follicle progenitors but reduces bulge region stem cells.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.